Try our beta test site

Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ (CTTNKTL-Ⅲ/Ⅳ)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Zhengzhou University
Sponsor:
Collaborators:
Second Hospital of Shanxi Medical University
Shanxi Province Cancer Hospital
Wuhan University
Wuhan TongJi Hospital
Wuhan Union Hospital, China
Qingdao University
Cancer Hospital of Guizhou Province
Xinyang Central Hospital
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Information provided by (Responsible Party):
Mingzhi Zhang, Zhengzhou University
ClinicalTrials.gov Identifier:
NCT01501149
First received: November 29, 2011
Last updated: July 15, 2015
Last verified: July 2015